John A Roberts - Net Worth and Insider Trading
John A Roberts Net Worth
The estimated net worth of John A Roberts is at least $53,458 dollars as of 2024-05-11. John A Roberts is the CEO of Cancer Genetics Inc and owns about 9,921 shares of Cancer Genetics Inc (CGIX) stock worth over $45,736. John A Roberts is also the CEO of Vyant Bio Inc and owns about 39,807 shares of Vyant Bio Inc (VYNT) stock worth over $7,723. Details can be seen in John A Roberts's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John A Roberts has not made any transactions after 2021-11-24 and currently still holds the listed stock(s).
Transaction Summary of John A Roberts
John A Roberts Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John A Roberts owns 2 companies in total, including Cancer Genetics Inc (CGIX) , and Vyant Bio Inc (VYNT) .
Click here to see the complete history of John A Roberts’s form 4 insider trades.
Insider Ownership Summary of John A Roberts
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CGIX | Cancer Genetics Inc | 2019-01-31 | Chief Executive Officer |
| VYNT | Vyant Bio Inc | 2021-11-24 | Chief Executive Officer |
John A Roberts Latest Holdings Summary
John A Roberts currently owns a total of 2 stocks. Among these stocks, John A Roberts owns 9,921 shares of Cancer Genetics Inc (CGIX) as of January 31, 2019, with a value of $45,736 and a weighting of 85.55%. John A Roberts also owns 39,807 shares of Vyant Bio Inc (VYNT) as of November 24, 2021, with a value of $7,723 and a weighting of 14.45%.
Latest Holdings of John A Roberts
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGIX | Cancer Genetics Inc | 2019-01-31 | 9,921 | 4.61 | 45,736 |
| VYNT | Vyant Bio Inc | 2021-11-24 | 39,807 | 0.19 | 7,723 |
Holding Weightings of John A Roberts
John A Roberts Form 4 Trading Tracker
According to the SEC Form 4 filings, John A Roberts has made a total of 0 transactions in Cancer Genetics Inc (CGIX) over the past 5 years. The most-recent trade in Cancer Genetics Inc is the acquisition of 6,181 shares on January 31, 2019, which cost John A Roberts around $42,650.
According to the SEC Form 4 filings, John A Roberts has made a total of 3 transactions in Vyant Bio Inc (VYNT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Vyant Bio Inc is the acquisition of 5,000 shares on November 24, 2021, which cost John A Roberts around $10,100.
Insider Trading History of John A Roberts
- 1
John A Roberts Trading Performance
GuruFocus tracks the stock performance after each of John A Roberts's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John A Roberts is -16.08%. GuruFocus also compares John A Roberts's trading performance to market benchmark return within the same time period. The performance of stocks bought by John A Roberts within 3 months outperforms 0 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John A Roberts's insider trading performs compared to the benchmark.
Performance of John A Roberts
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.88 | | | | | |
| Relative Return to S&P 500(%) | -5.22 | | | | | |
John A Roberts Ownership Network
John A Roberts Owned Company Details
What does Cancer Genetics Inc do?
Who are the key executives at Cancer Genetics Inc?
John A Roberts is the Chief Executive Officer of Cancer Genetics Inc. Other key executives at Cancer Genetics Inc include President & Discovery Services Ralf Brandt , Chief Financial Officer Michael Glenn Miles , and EVP Precision Medicine William Lansing Finger .
Cancer Genetics Inc (CGIX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cancer Genetics Inc (CGIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cancer Genetics Inc (CGIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cancer Genetics Inc (CGIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cancer Genetics Inc Insider Transactions
John A Roberts Mailing Address
Above is the net worth, insider trading, and ownership report for John A Roberts. You might contact John A Roberts via mailing address: C/o Cancer Genetics, Inc., 201 Route 17 North, 2nd Floor, Rutherford Nj 07070.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
